Saltar al contenido
Salud cardiovascularArtículo de investigación3 min read

Diabetes and hypertension together: higher coronary disease and stroke risk, not heart failure

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Diabetes, hypertension, and cardiovascular disease development. · Journal of translational medicine · 2022 · Artículo original ↗

Idea principal

In Taiwan's national insurance database, adding hypertension to type 2 diabetes was associated with more coronary artery disease (HR 2.22, 95% CI 2.07 to 2.37) and stroke (HR 1.19), and adding diabetes to hypertension with more coronary disease (HR 1.69). Heart failure risk did not differ in any comparison. This is claims-based cohort data, so diagnosis timing and lifestyle factors may be imperfectly captured.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Type 2 diabetes (T2DM) and hypertension (HTN) often occur together, but it is unclear how much the second condition adds to cardiovascular risk depending on which came first. The authors compared cardiovascular outcomes in people with T2DM with and without later HTN, people with HTN with and without later T2DM, and people with both conditions by which they had first.

Población y método

Retrospective matched cohort study using Taiwan's National Health Insurance Research Database, January 1, 2000 to December 31, 2018. The authors identified 16,236 matched pairs of T2DM participants with and without HTN, 53,509 pairs of HTN participants with and without T2DM, and 21,158 pairs of people with both conditions, one with T2DM history and one with HTN history. Cox proportional-hazard models estimated the risk of cardiovascular disease. Mean follow-up was 6.75 years.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Mean incidence of coronary artery disease was 16.80 per 1000 person-years in the T2DM cohorts, 23.18 in the HTN cohorts and 31.53 in the comorbid cohorts.
  2. 2
    T2DM with versus without HTN: adjusted HR 2.22 (95% CI 2.07 to 2.37) for coronary artery disease, 1.19 (1.16 to 1.23) for stroke and 0.92 (0.82 to 1.02) for heart failure.
  3. 3
    HTN with versus without T2DM: adjusted HR 1.69 (1.55 to 1.84) for coronary artery disease, 1.25 (1.21 to 1.30) for stroke and 0.98 (0.93 to 1.05) for heart failure.
  4. 4
    Among people with both conditions, previous T2DM versus previous HTN: adjusted HR 2.78 (2.37 to 3.27) for coronary artery disease, 1.20 (1.13 to 1.28) for stroke and 0.95 (0.88 to 1.03) for heart failure. Heart failure risk differed in none of the comparisons.

Límites e incertidumbre

  1. 1
    The data come from an insurance claims database, so diagnoses, onset dates and the order of T2DM and HTN depend on coding, and the abstract does not list which confounders were adjusted for.
  2. 2
    Blood pressure and glucose levels, medicines and lifestyle such as exercise or diet are not described in the abstract, so risk cannot be tied to how well either condition was controlled.
  3. 3
    The population is Taiwanese and the mean follow-up was 6.75 years, so results may differ elsewhere or over longer periods. This reading is based on the abstract only.

Relevancia práctica

Having both diabetes and high blood pressure was linked to noticeably more coronary artery disease and somewhat more stroke than having one alone, so managing both conditions matters. It does not tell you your own risk or what treatment you need; targets and medicines belong in a conversation with your clinician.

Tus datos

If you have a home blood pressure cuff or glucose sensor, record readings under consistent conditions, such as the same time of day and posture, and look at the trend over weeks rather than single numbers. Resting heart rate and activity trends from a wearable can add context but do not replace clinical measurements.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

We aimed to compare cardiovascular risks among participants with T2DM with and without subsequent HTN and participants with HTN with and without subsequent T2DM.

Methods

From January 1, 2000, to December 31, 2018, we identified 16,236 matched pairs of T2DM participants with and without HTN (T2DM cohorts), 53,509 pairs of HTN participants with and without T2DM (HTN cohorts), and 21,158 pairs of comorbid HTN and T2DM participants with T2DM history or HTN history (comorbid cohorts) from Taiwan's National Health Insurance Research Database. Cox proportional-hazard models were used to calculate the risk of cardiovascular disease.

Results

The mean follow-up time of this study was 6.75 years. Mean incident rates of coronary artery disease for T2DM cohorts, HTN cohorts, and comorbid cohorts were 16.80, 23.18, and 31.53 per 1000 person-years, respectively. The adjusted hazard ratios (HRs) (95% confidence intervals [95% CIs]) for incident coronary artery disease, stroke, and heart failure in T2DM participants with versus without HTN were 2.22 (2.07-2.37), 1.19 (1.16-1.23), and 0.92 (0.82-1.02), respectively; the adjusted HRs for HTN participants with versus without T2DM were 1.69 (1.55-1.84), 1.25 (1.21-1.30), and 0.98 (0.93-1.05), respectively; the adjusted HRs for comorbid T2DM and HTN participants with previous T2DM versus previous HTN were 2.78 (2.37-3.27), 1.20 (1.13-1.28), and 0.95 (0.88-1.03), respectively.

Conclusions

This nationwide cohort study demonstrated that both T2DM with subsequent HTN and HTN with subsequent diabetes were associated with higher cardiovascular disease risks.

Fuentes y atribución

Diabetes, hypertension, and cardiovascular disease development.

Yen FS, Wei JC, Chiu LT, Hsu CC, Hwu CM.

Journal of translational medicine · 2022-01-03

DOI: 10.1186/s12967-021-03217-2 ↗PubMed · 34980154 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis observacional

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Salud cardiovascular →